课题基金 / 基金详情

PA-20-070 Improving Medication Safety and Nursing Workflow during COVID Through eMAR Redesign

PA-20-070 Improving Medication Safety and Nursing Workflow during COVID Through eMAR Redesign
PA-20-070 通过 eMAR 重新设计改善新冠肺炎期间的用药安全和护理工作流程
批准号:
10175229
负责人:
Raj M Ratwani
金额:
$24.53万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2023-04-30

项目摘要

项目成果

Raj M Ratwani的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/摘要 拟议的研究是对AHRQ PA-20-070的直接回应。我们的目标是支持护理工作流程, 减少与电子给药记录(eMAR)相关的患者安全危害, (1)了解COVID-19前和COVID-19药物管理 通过分析健康信息技术和与护士的虚拟访谈的工作流程;和(2) 开发并向医疗机构传播药物管理工作流程风险评估工具 和卫生信息技术测试案例,以评估eMAR的可用性和安全性。我们将开发一个广泛的 了解用药管理工作流程的变化和医疗信息技术的需求, 通过比较与药物相互作用产生的电子数据, 技术在各个时期的应用。然后我们将与护士进行面谈, 验证药物管理工作流程,并生成流程图,以比较COVID-19前与 COVID-19药物管理工作流程,旨在识别安全风险。这些数据将告知 风险评估工具和可用性测试用例的开发将分发给医疗机构 和技术供应商。 该项目利用了研究团队在人为因素、健康信息、 技术、信息学和数据科学以及安全科学。我们的研究团队包括医生,护士, 人为因素工程师。该提案涉及提案征集的基本方面, 提供关于药物管理安全和健康信息技术的新见解, 新冠肺炎等大流行病的挑战。这项研究的贡献将包括一个基本的 了解医疗信息技术在药物管理过程中的作用,重点是 信息流,设计和开发医疗保健系统的风险评估工具和测试用例, 技术供应商,以应对COVID-19期间患者安全风险的增加。
英文摘要
PROJECT SUMMARY/ABSTRACT The proposed research is in direct response to AHRQ PA-20-070. We aim to support nursing workflow and reduce patient safety hazards associated with electronic medication administration records (eMARs) during pandemics such as COVID-19 by: (1) understanding pre-COVID-19 and COVID-19 medication administration workflows through analysis of health information technology and virtual interviews with nurses; and (2) developing and disseminating a medication administration workflow risk assessment tool to healthcare facilities and health information technology test cases to assess eMAR usability and safety. We will develop a broad understanding of medication administration workflow changes and health information technology needs pre COVDI-19 and during COVID-19 by comparing electronic data generated in interactions with medication administration technology these respective time periods. We will then conduct interviews with nurses to validate the medication administration workflows, and generate process maps to compare pre-COVID-19 vs. COVID-19 medication administration workflows with the goal of identifying safety risks. These data will inform the development of the risk assessment tool and usability test cases to be disseminated to healthcare facilities and technology vendors. This project utilizes the extensive expertise of the research team in human factors, health information technology, informatics and data science, and safety science. Our research team includes physicians, nurses, and human factors engineers. The proposal addresses fundamental aspects of the call for proposals by providing new insights on medication administration safety and health information technology to address challenges of pandemics such as COVID-19. Contributions from this research will include a fundamental understanding of the role of health information technology during medication administration with a focus on information flow, design, and development of a risk assessment tool and test cases for healthcare systems and technology vendors to meet the increased risks to patient safety during COVID-19.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transforming Patient Safety Event Data into Actionable Insights through Advanced Analytics
Transforming Patient Safety Event Data into Actionable Insights through Advanced Analytics
Transforming Patient Safety Event Data into Actionable Insights through Advanced Analytics
Improving Patient Safety and Clinician Cognitive Support Through eMAR Redesign
国内基金
海外基金
CDC20-HDAC6-POLD1轴调控肺腺癌免疫微环境的机制研究
  • 批准号:
    2026JJ80369
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    胡智
  • 依托单位:
CCL20/CCR6/SEMA3C信号轴通过EMT及肿瘤干细胞互作调控阴茎癌转移的分子机制研究
  • 批准号:
    2026JJ50313
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    胡希恒
  • 依托单位:
IFT20 抑制肝星状细胞活化并诱导其凋亡的机制研究
新型可降解聚酯P20-2C联合利福平根除关节假体表面细菌生物膜的机制与应用研究
  • 批准号:
    2026JJ82609
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    朱怡
  • 依托单位: